Literature DB >> 21119558

Disseminated intravascular large B cell lymphoma with slowly decreasing high-density lipoprotein cholesterol.

Amit Garg1, Elizabeth M Hosfield, Leslea Brickner.   

Abstract

Intravascular large B cell lymphoma (IVLBCL) is a rare type of extranodal large B cell lymphoma in the lumina of small vessels. Low high-density lipoprotein cholesterol (HDL-C) is associated with sepsis, malignancy, and death. Recent evidence suggests an inverse relationship between HDL-C and non-Hodgkin lymphoma. We report the case of a 71-year-old female who presented with decreasing HDL-C for years prior to diagnosis of IVLBCL. The patient developed nonspecific symptoms, including dizziness, gait instability, fatigue, tinnitus, and weight loss. Although malignancy was high on the differential, no diagnosis was made antemortem. The diagnosis of disseminated intravascular large B cell lymphoma was made postmortem in multiple organ systems. The presentation of IVLBCL is nonspecific and misleading. To our knowledge this is the second known case report of low HDL-C preceding diagnosis of IVLBCL, but the first case documenting low HDL-C years prior to diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21119558     DOI: 10.1097/SMJ.0b013e3181fcd4b9

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

Authors:  Andreas G Moraitis; Lita A Freeman; Robert D Shamburek; Robert Wesley; Wyndham Wilson; Cliona M Grant; Susan Price; Stephen Demosky; Seth G Thacker; Abdalrahman Zarzour; Ronald L Hornung; Frank Pucino; Gyorgy Csako; Cheryl Yarboro; Iain B McInnes; Takashi Kuroiwa; Dimitrios Boumpas; V Koneti Rao; Gabor G Illei; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2014-10-05       Impact factor: 4.766

Review 2.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

3.  Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis.

Authors:  Sharon Hensley Alford; George Divine; Chun Chao; Laurel A Habel; Nalini Janakiraman; Yun Wang; Heather Spencer Feigelson; Delia Scholes; Doug Roblin; Mara M Epstein; Lawrence Engel; Suzanne Havstad; Karen Wells; Marianne Ulcickas Yood; Joan Fortuny; Christine Cole Johnson
Journal:  Cancer Causes Control       Date:  2017-11-30       Impact factor: 2.506

4.  A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective Study.

Authors:  Jiadai Xu; Zheng Wei; Yian Zhang; Chen Chen; Jing Li; Peng Liu
Journal:  Biomed Res Int       Date:  2018-12-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.